Innate Pharma
IPHA
£1.33
Share price
-1.36%
Change (1 day)
-17.46%
Change (1 year)
Categories
Revenue for Innate Pharma (IPHA)
Revenue in 2024: £9.62 Million
According to Innate Pharma
's latest financial reports the company's current revenue (TTM 
) is £9.62 Million. In 2024 the company made a revenue of £9.62 Million a decrease over the revenue in the year 2023 that were of £42.04 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Innate Pharma from 2005 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | £9.62 M | -77.11% |
| 2023 | £42.04 M | 7.88% |
| 2022 | £38.97 M | 287.78% |
| 2021 | £10.05 M | -80.14% |
| 2020 | £50.62 M | -10.13% |
| 2019 | £56.32 M | -15.91% |
| 2018 | £66.98 M | 133.44% |
| 2017 | £28.69 M | -33.72% |
| 2016 | £43.29 M | 201.72% |
| 2015 | £14.34 M | 1674.86% |
| 2014 | £0.8 M | -93.59% |
| 2013 | £12.62 M | 25.45% |
| 2012 | £10.05 M | 41.8% |
| 2011 | £7.09 M | 68.46% |
| 2010 | £4.21 M | -48.02% |
| 2009 | £8.1 M | -38.81% |
| 2008 | £13.24 M | -13.41% |
| 2007 | £15.29 M | 86.54% |
| 2006 | £8.19 M | 286.35% |
| 2005 | £2.12 M |